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890Left Bundle Branch Block and
Dyssynchrony in CRT ResponseDoes it Take Two to Tango?We read with great interest the papers by Bartko et al.
(1) and Gorcsan et al. (2) on the predictive value of
dyssynchrony markers for cardiac resynchronization
therapy (CRT) response, irrespective of the presence
of left bundle branch block (LBBB).
In the first study, Bartko et al. (1) provided argu-
ments for a causative association between papillary
muscle resynchronization and reduction of functional
mitral regurgitation (FMR) following CRT, irrespective
of the presence of LBBB. Accordingly, it could be
interpreted from their study that the cause of (papil-
lary muscle) dyssynchrony, either pure electrical or
pure mechanical, is of no or lesser relevance with re-
gard to CRT response and reduction of FMR.
Although we acknowledge the pathophysiological
contribution of papillary dyssynchrony to FMR (3),
we have some concerns about the definition of FMR
nonresponders as a comparator or control group.
The latter group had only mild FMR at baseline
compared with the FMR responders, whereas the
FMR responders had pronounced FMR severity at
baseline. Therefore, the mild FMR in the nonre-
sponder group might preclude any meaningful early
or late reduction of FMR, and the conclusions with
respect to the independent causative role of papil-
lary dyssynchrony in FMR might be less robust than
they seem. Likewise, FMR responders had much
more interventricular and papillary muscle dyssyn-
chrony at baseline (greater prevalence of typical
LBBB?), which made a comparative analysis on the
effects of resynchronization in non-FMR responders
difficult.
Also, from a pathophysiological point of view, it
would have been of interest to see whether FMR was
significantly reduced immediately or shortly after
CRT implantation. It might be relevant to explore the
differential contribution of restored papillary muscle
synchrony to early FMR reduction versus the reduc-
tion of FMR due to reverse remodeling that emerged
at later stages of CRT. It is known that early decreases
in FMR following CRT are related to acute improve-
ments of left ventricular contractility and blunted
papillary muscle dyssynchrony (3). We believe that
addressing these issues would have strengthened the
conclusions of their study.
In another paper in this issue of iJACC, Gorcsan
et al. (2) expanded their previously published find-
ings on the use of strain-based systolic stretch index(SSI) and its association with CRT response at a
multicenter level. In addition, the investigators
mentioned that SSI yielded excellent predictive
values in both patients with LBBB and patients with
non-LBBB. Because of the results of subgroup ana-
lyses in large randomized trials that showed poor
response rates in non-LBBB, this was again a
remarkable, but interesting, finding (4,5). Also, in line
with the report from Bartko et al. (1), the study of
Gorcsan et al. (2) suggested that the cause or patho-
genesis of dyssynchrony, being either electrical or
pure mechanical, might be of less importance with
regard to CRT response. Although our group is
convinced of the strong pathophysiological basis of
SSI in typical LBBB (6), it remains to be explored
whether a similar or different pathophysiology gov-
erns SSI in non-LBBB.
Although the investigators mentioned non-LBBB,
separate data on the population with non-LBBB
were not reported in their study, which is important
because of the controversy on CRT benefit in non-
LBBB and/or right bundle branch block. Also, as a
receiver-operating characteristic analysis was not re-
ported (absence of non-CRT control group) and
because CRT response is probably continuously
related to SSI, clinicians may speculate on the added
value of SSI or any SSI threshold to be used in cardi-
ology practice. A low SSI value may not preclude pa-
tients from being treated with CRT.
Finally, a common observation in both studies was
that CRT response was associated with echo-
dyssynchrony measures, irrespective of the presence
of LBBB. Does this mean that echocardiography is
taking back control over the selection of CRT candi-
dates, after it was discredited a decade ago (7)? We
share a common belief with all of the investigators
that echocardiography plays an important role in the
evaluation of electromechanical dyssynchrony, but
many issues remain to be solved before it can re-enter
the clinical arena.Simon Calle, MD
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to CRT (PROSPECT) trial. Circulation 2008;117:2608–16.THE AUTHORS REPLY:We appreciate the thorough analysis by Dr. Calle
and colleagues on the significance of papillary
muscle dyssynchronymediated functional mitral
regurgitation (FMR) and the beneficial effect of
cardiac resynchronization therapy (CRT) (1). The
presence of FMR is a central heart failure driving
force with an adverse prognosis, despite guideline-
directed medical therapy (2,3). Although our clin-
ical data support the hypothesis of papillary muscle
dyssynchrony as an early driver of FMR improve-
ment, we do acknowledge that the study design is
hypothesis-generating and that these findings need
to be confirmed by randomized trials. We agree that
the benefits of CRT most likely follow a biphasic
pattern with immediate improvements in dyssyn-
chrony, restoration of organized flow, and improved
flow acceleration as indexes for left ventricular
diastolic filling (4), improved closing-tethering force
balance (5), and, as a result, improvements of mitral
valve coaptation. Long-term benefits might be morerelated to reverse ventricular remodeling, and
therefore, improved tethering patterns. Potential
interaction of acute effects with long-term effects
are hardly separable and would need testing in a
controlled in vitro environment. Due to the het-
erogeneity in the anatomy and pathology related to
the term atypical left bundle branch block, this term
is not recommended in electrocardiographic stan-
dardization guidelines and was therefore not
a pre-defined electrocardiographic metric in this
study.Philipp E. Bartko, MD, PhD
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